Madison Brengle: American to sue WTA and ITF for 'injuries caused by drug testing'
American Madison Brengle is suing the Women’s Tennis Association and the International Tennis Federation for injuries she alleges were caused by repeated anti-doping tests.
A medical condition that meant Brengle, 28, reacted badly to needle injections was ignored, says her lawyer.
Brengle has permanent swelling and weakness in her serving arm and hand and had to withdraw from tournaments.
The world number 83 is likely to seek more than $10m (£7m) in damages.
“Tennis authorities ignored evidence of her professionally-diagnosed condition and refused to provide alternative testing or a medical accommodation,” said lawyer Peter Ginsberg.
Brengle, who has won more than $2.1m (£1.5m) in prize money, said: “I am bringing this action in an effort to force those who control the sport I love to understand that players are not commodities and should be treated with respect and dignity.
“The unbridled authority of officials to subject players to the kind of abuse I suffered cannot be tolerated; players must have a say in matters involving our health and safety.”
An ITF spokesperson told BBC Sport: “We are aware of Ms Brengle’s statement that she has filed a lawsuit in the USA relating to her alleged treatment in connection with drug-testing under the Tennis Anti-Doping Programme.
“The ITF has not been served with the lawsuit to date. As such, no further comment on this matter will be made at this time.”
The WTA has yet to comment.